MeSH tree: C04.557.470.670.380.515
A novel, multi-analyte test developed by researchers at the Johns Hopkins Kimmel Cancer Center, its Ludwig Center and the Johns Hopkins Department of Neurosurgery can accurately identify brain cancers using small samples ...
Aug 27, 2025
0
17
A study co-led by researchers at The Hospital for Sick Children (SickKids) and the University of Toronto's Temerty Faculty of Medicine has uncovered why some very-high-risk brain tumors are resistant to radiation—and identified ...
Aug 18, 2025
0
24
Childhood brain tumor survival depends on the type of tumor. Comparing survival rates across countries is difficult, because brain tumors aren't recorded in the same way everywhere in Europe. A new study led by the Princess ...
Jul 28, 2025
0
18
A specially engineered antibody that can accurately deliver RNA treatments into hard-to-reach and hard-to-treat tumors significantly improved survival and reduced tumor sizes in animal models, according to a study reported ...
Jul 17, 2025
0
83
Medulloblastomas are one of the most common childhood brain cancers. Group-3 medulloblastomas are particularly aggressive and incurable, contributing to childhood cancer deaths. Led by University of Michigan researchers, ...
May 19, 2025
0
20
Medulloblastoma is one of the most common malignant tumors of the central nervous system (CNS) in children and adolescents. It develops in the area of the cerebellum, which is responsible for movement coordination, among ...
May 7, 2025
0
17
Researchers at Baylor College of Medicine, Texas Children's Hospital, the Hospital for Sick Children in Toronto and collaborating institutions reveal in Nature Cell Biology a strategy that helps medulloblastoma, the most ...
Apr 23, 2025
0
24
Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common type of malignant brain tumor in children—and potentially sparing young patients from unnecessary treatments ...
Mar 12, 2025
0
16
Two new studies represent a big step toward developing innovative molecular therapies capable of disrupting the uncontrollable growth of cancers at their roots.
Feb 13, 2025
0
32
Scientists at The Hospital for Sick Children (SickKids) have discovered a way to stop tumor growth before it starts for a subtype of medulloblastoma, the most common childhood malignant brain cancer.
Feb 4, 2025
0
53
